Retinoblastoma (pRb) protein immunoexpression in colorectal cancer

Anticancer Research

Volumn 17, Issue 4 A, 1997, Pages 2593-2597

  Chetty, Runjan ^a   Subramoney, Terence ^a   Singh, Jaimendra ^a   Harilal, Pranitha ^a  

^a UNIVERSITY OF NATAL   (South Africa)

Author keywords

Colorectal cancer; Immunoexpression; Retinoblastoma protein (pRb)

Indexed keywords

RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CELL CYCLE; CLINICAL FEATURE; COLON RESECTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; RETINOBLASTOMA PROTEIN;

EID: 0030838950     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Clurman BE and Roberts JM: Cell cycle and cancer. J Natl Cancer Inst 87: 1499-1501, 1995.
2. Lee WH, Shew JY, Hong FD et al: The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 329: 642-645, 1987.
3. Cordon-Cardol C, Wartinger D, PetrylakJ D et al: Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Ins 84: 1251-1256, 1992.
4. Cordon-Cardo C, Richon VM: Expression of the retinoblastoma protein is regulated in normal human tissues. Am J Pathol 144: 500-510, 1994.
5. Constancia M, Seruca R, Carneiro F, Suva F, Castedo S: Retinoblastoma gene structure and product expression in human gastric carcinomas. Br J Cancer 70: 1018-1024, 1994.
6. Cance WG, Brennan MF, Dudas ME, Huang C-M, Cordon-Cardo C: Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 323: 1457-1462, 1990.
7. Holm R, Nesland JM: Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland. J Pathol 172: 267-272, 1994.
8. Martinez JC, Piris MA, Sanchez-Beato M er al: Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki-67 growth fraction. J Pathol 169: 405-412, 1993.
9. Xu H-J, Hu S-X, Benedict WF: Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total Rb protein level. Oncogene 6: 1139-1146, 1991.
10. Meling GI, Lothe RA, Borresen A-L et al: Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis. Br J Cancer 64: 475-480, 1991.
11. Gope R, Christensen MA, Thorson A et al: Increased expression of the retinoblastoma gene in human colorectal carcinomas relative to normal colonic mucosa. J Natl Cancer Inst 82: 310-314, 1991.
12. Ali AA, Marcus JN, Harvey JP et al: RB1 protein in normal and malignant human colorectal tissue and colon cancer cell lines. FASEB J 7: 931-937, 1993.
13. Fukuda K, Monden T, Yamamoto H et al: Immunohistochemical study of retinoblastoma gene expression in colorectal carcinomas. Int J Oncol 4: 117-121, 1994.
14. Yamamoto H, Monden T, Ikeda K et al: Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer. Br J Cancer 71: 1231-1236, 1995.
15. Fearon ER and Vogelstein B: A genetic model for colorectal tumourigenesis. Cell 61: 759-767, 1990.
16. Bussey HJR: Familial polyposis coli: Family studies, histopathology, differential diagnosis, and results of treatment, pp.1-37, The Johns Hopkins University Press, Baltimore, 1975.
17. Bufill JA: Colorectal cancer: Evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 113: 779-788, 1990.
18. Lynch HT, Smyrk TC, Watson P et al: Genetics, natural history, tumour spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review. Gastroenterology 104: 1535-1549, 1993.
19. Picksley SM and Lane DP: p53 and Rb: their cellular roles. Curr Opin Cell Biol 6: 853-858, 1994.
20. Presti JC, Reuter VE, Galan T, Fair WF, Cordon-Cardo C: Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 51: 5405-5409, 1991.
21. Ishikawa J, Xu H-J, Hu S-T et al: Inactivation of the retinoblastoma gene in human bladder cancer and renal cell carcinomas. Cancer Res 57: 5736-5737, 1991.
22. Xu H-J, Hu S-X, Cagle PT, Moore PT, Benedict WF: Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res 51: 2735-2739, 1991.
23. Logothetis CJ, Xu H-J, Ro JY et al: Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladdercancer. J Natl Cancer Inst 84: 1256-1261, 1992.
24. Varley JM, Armour J, Swallow JE et al: The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumors. Oncogene 4: 725-729, 1989.
25. Kornblau SM, Xu H-J, Giglio A et al: Clinical implications of altered retinoblastoma protein expression in acute myelogenous leukemia. Cancer Res 52: 4587-4590, 1992.
26. Bartek J, Vojtesek B, Grand RJA, Gallimore PH, Lane DP: Cellular localization and T antigen binding of the retinoblasloma protein. Oncogene 7: 101-108, 1992.
27. Bookstein R, Rio P, Madreperla SA et al: Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci (USA) 87: 7762-7766, 1990.
28. Jiang W, Zhang Y-J, Kahn SM et al: Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci (USA) 90: 9026-9030, 1993.